Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed ETP-ALL
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Venetoclax
Related studies linked through entity extraction aliases.
Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell Transplant
- Status
- WITHDRAWN
- Phase
- PHASE2
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Venetoclax, Rituximab and Nivolumab in Combination for the Treatment of Richter's Transformation Arising From Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Cladribine Venetoclax in Monocytic AML
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML
- Status
- RECRUITING
- Phase
- PHASE2
Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL)
- Status
- WITHDRAWN
- Phase
- PHASE2
Patients Treated in Real Life With VEnetoclax for WAldenström Macroglobulinemia
- Status
- RECRUITING
- Phase
- N/A
Optimize First-line Treatment for AL Amyloidosis With t (11; 14)
- Status
- RECRUITING
- Phase
- NA
A Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, and Activity of Venetoclax in Combination With Oral Decitabine/Cedazuridine (ASTX727) in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)
- Status
- RECRUITING
- Phase
- PHASE1
Safety and Efficacy of RVU120 Combined With Venetoclax for Treatment of Relapsed/Refractory AML
- Status
- RECRUITING
- Phase
- PHASE2
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Venetoclax in Combination With Azacitidine (VEN/AZA) Followed by Donor Lymphocyte Infusion (DLI) for Patients With Very High-Risk Acute Myeloid Leukemia (AML) Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)
- Status
- SUSPENDED
- Phase
- PHASE1
Combination Salvage Therapy With Venetoclax and Decitabine in Relapsed/Refractory AML
- Status
- RECRUITING
- Phase
- PHASE2
CIML NK Cells With Venetoclax for AML
- Status
- RECRUITING
- Phase
- PHASE1
Acute Myeloid Leukemia Treated With With NETrin Abs in Combination With [AZACITIDINE + VENETOCLAX]
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2